Black Diamond Therapeutics, Inc. (BDTX) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts BDTX Hot Sheet
Join SI Premium – FREE
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q2 EPS of ($0.36), $0.03 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Stem Inc. (STEM) to Buy
- Costco (COST) Tops Q4 EPS by 20c
- Prime Medicine (PRME) Reiterated at Market Outperform by Citizens as PM647 Application Cleared
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
